ESG
Governance Structure
Board of Directors
| Sort | Name | Title | Work Status | Appointment | Term | Liability Insurance |
|---|---|---|---|---|---|---|
| Executive Directors | Yang-gon Jin | Chairman | Non-regular | 2024.03.26 | 3yrs | Covered |
| Ki-hong Ahn | CEO | Regular | 2024.03.26 | 3yrs | Covered | |
| Chang-yoon Lim | Director | Non-regular | 2024.03.26 | 3yrs | C00overed | |
| Chang-sup Shin | Director | Regular | 2024.03.26 | 3yrs | Covered | |
| Independent Directors | Jeong-sang Lee | Director | Non-regular | 2024.03.26 | 3yrs | Covered |
| Jae-hoon Kim | Director | Non-regular | 2024.03.26 | 3yrs | Covered |
Board of Directors Status
No. |
Date | Agenda | Approval | Board Members' Names | |||||
|---|---|---|---|---|---|---|---|---|---|
| Yang-gon Jin | Ki-hong Ahn | Chang-yoon Im | Chang-sup Shin | Jeong-sang Lee | Jae-hoon Kim | ||||
Attendance Rate 100.0% |
Attendance Rate 100.0% |
Attendance Rate 100.0% |
Attendance Rate 100.0% |
Attendance Rate 90.0% |
Attendance Rate 100.0% |
||||
| Agree/Disagree | |||||||||
| 1 | 2024.02.19 | Investment in and Loans to Subsidiaries | Approved | Agreed | Agreed | Agreed |
- |
Agreed |
Agreed |
| 2 | 2024.02.19 | Financial Support through Capital Increase Participation in Subsidiary (Oblato, Inc.) | Approved |
Agreed |
Agreed |
Agreed |
- |
Agreed |
Agreed |
| 3 | 2024.02.28 | Approval of the Financial Statements for the 24th Fiscal Year (2023) | Approved |
Agreed |
Agreed |
Agreed |
- |
Agreed |
Agreed |
| 4 | 2024.02.28 | Convene the 24th Annual General Meeting of Shareholders and Determine Its Agenda | Approved |
Agreed |
Agreed |
Agreed |
- |
Agreed |
Agreed |
| 5 | 2024.03.22 | Third‑Party Allocation of New Shares | Approved |
Agreed |
Agreed |
Agreed |
- |
Agreed |
Agreed |
| 6 | 2024.03.22 | Issuance of the 16th Convertible Bonds | Approved |
Agreed |
Agreed |
Agreed |
- |
Agreed |
Agreed |
| 7 | 2024.03.26 | Appointment of the Temporary Chairman |
Approved |
Agreed |
Agreed |
Agreed |
- |
Agreed |
Agreed |
| 8 | 2024.03.26 | Appointment of the Chairman | Approved |
Agreed |
Agreed |
Agreed |
- |
Agreed |
Agreed |
| 9 | 2024.03.26 | Appointment of the Chief Executive Officer | Approved |
Agreed |
Agreed |
Agreed |
- |
Agreed |
Agreed |
| 10 | 2024.04.03 | Issuance of new shares allotted to a third party | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Non-attendance |
Agreed |
| 11 | 2024.05.29 | Granting Restricted Stock Units (RSU) of HLB Therapeutics | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 12 | 2024.06.28 | Amendment of the Agreement between HLB Therapeutics and RegeneRX | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 13 | 2024.06.28 | Closure of the Medical Devices Division Branch | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 14 | 2024.07.02 | Providing a Joint Guarantee for Renewal of the Corporate Credit Card Holder of GTree Pharmaceutical | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 15 | 2024.07.18 | HLB Therapeutics' participation in ITI third-party allocation paid-in capital increase | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 16 | 2024.09.03 | Approval of Other Related‑Party Transactions for 2024 | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Non-attendance |
Agreed |
| 17 | 2024.09.03 | Amendment of the Control Regulations on Transactions with Special Related Parties | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Non-attendance |
Agreed |
| 18 | 2024.09.11 | New Loans from Financial Institutions and Provision of Collateral | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 19 | 2024.09.23 | Approval of a Spin‑off | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 20 | 2024.10.15 | Determine the Record Date and Shareholders Entitled to Rights | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 21 | 2024.10.15 | Convene an Extraordinary General Meeting of Shareholders | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 22 | 2024.10.28 | Acquisition of Shares of Other Corporations | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 23 | 2024.11.15 | Issuance of the 17th Convertible Bonds by HLB Therapeutics Co., Ltd. | Approved |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
Agreed |
| 24 | 2024.11.21 | HLB Therapeutics' participation in ITI third-party allocation paid-in capital increase |
Approved |
- |
- |
Agreed |
Agreed |
Agreed |
Agreed |
| 25 | 2024.12.19 | Transfer of Capital Reserve to Capital (Distribution of Stock Dividend) | Approved |
Agreed |
Agreed |
Agreed |
Agreed | Agreed |
Agreed |
Committee
| Sort | Chairman | Member | Regulations |
|---|---|---|---|
| ESG Committee | Ki-hong Ahn | Jeong-sang Lee, Jae-hoon Kim |
|
Standing Auditor
| Name | Appointment | Term | Liability Insurance |
|---|---|---|---|
| Yeok-dong Kim | 2024.03.26 | 3yrs | Covered |
External Auditor
| Name | Appointment | Term | Recent Opinion |
|---|---|---|---|
Samjong Accounting Corporation |
2025.01 | 3yrs | Clean Opinion |